Shoulder Innovations, Inc. (NYSE: SI) Stock Competitors & Peer Comparison
See SI's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for SI and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SI | $17.89 | -0.33% | 371.5M | -10.36 | -$1.73 | N/A |
| ALC | $66.30 | -2.15% | 32.3B | 20.85 | $3.18 | +0.54% |
| STE | $209.90 | -0.18% | 20.5B | 20.14 | $10.42 | +1.23% |
| QDEL | $10.77 | +1.32% | 734.4M | 8.04 | $1.34 | N/A |
| MLAB | $125.29 | -1.46% | 701.1M | 12.64 | $9.91 | +0.50% |
| BWAY | $13.46 | +0.00% | 527.9M | 34.19 | $0.39 | N/A |
| MASS | $9.92 | -0.50% | 407M | -16.53 | -$0.60 | N/A |
| MOBI | $10.71 | -0.56% | 356.1M | -0.57 | -$18.78 | N/A |
| ANIK | $20.84 | -0.33% | 278.9M | 42.53 | $0.49 | N/A |
| LAB | $0.71 | +2.72% | 277.6M | -10.13 | -$0.07 | N/A |
Stock Comparison
Alcon Inc. (NYSE: ALC)
SI vs ALC Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 371.5M. In comparison, ALC has a market cap of 32.3B. Regarding current trading prices, SI is priced at $17.89 on the NYSE, while ALC trades at $66.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.36, whereas ALC's P/E ratio is 20.85. In terms of profitability, SI's ROE is -0.26%, compared to ALC's ROE of +0.03%. Regarding short-term risk, SI is more volatile compared to ALC. This indicates higher risk in terms of short-term price fluctuations for SI.Check ALC's competition here
STERIS plc (NYSE: STE)
SI vs STE Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 371.5M. In comparison, STE has a market cap of 20.5B. Regarding current trading prices, SI is priced at $17.89 on the NYSE, while STE trades at $209.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.36, whereas STE's P/E ratio is 20.14. In terms of profitability, SI's ROE is -0.26%, compared to STE's ROE of +0.11%. Regarding short-term risk, SI is more volatile compared to STE. This indicates higher risk in terms of short-term price fluctuations for SI.Check STE's competition here
QuidelOrtho Corporation (NASDAQ: QDEL)
SI vs QDEL Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 371.5M. In comparison, QDEL has a market cap of 734.4M. Regarding current trading prices, SI is priced at $17.89 on the NYSE, while QDEL trades at $10.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.36, whereas QDEL's P/E ratio is 8.04. In terms of profitability, SI's ROE is -0.26%, compared to QDEL's ROE of -0.55%. Regarding short-term risk, SI is less volatile compared to QDEL. This indicates lower risk in terms of short-term price fluctuations for SI.Check QDEL's competition here
Mesa Laboratories, Inc. (NASDAQ: MLAB)
SI vs MLAB Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 371.5M. In comparison, MLAB has a market cap of 701.1M. Regarding current trading prices, SI is priced at $17.89 on the NYSE, while MLAB trades at $125.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.36, whereas MLAB's P/E ratio is 12.64. In terms of profitability, SI's ROE is -0.26%, compared to MLAB's ROE of +0.03%. Regarding short-term risk, SI is less volatile compared to MLAB. This indicates lower risk in terms of short-term price fluctuations for SI.Check MLAB's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
SI vs BWAY Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 371.5M. In comparison, BWAY has a market cap of 527.9M. Regarding current trading prices, SI is priced at $17.89 on the NYSE, while BWAY trades at $13.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.36, whereas BWAY's P/E ratio is 34.19. In terms of profitability, SI's ROE is -0.26%, compared to BWAY's ROE of +0.13%. Regarding short-term risk, SI is more volatile compared to BWAY. This indicates higher risk in terms of short-term price fluctuations for SI.Check BWAY's competition here
908 Devices Inc. (NASDAQ: MASS)
SI vs MASS Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 371.5M. In comparison, MASS has a market cap of 407M. Regarding current trading prices, SI is priced at $17.89 on the NYSE, while MASS trades at $9.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.36, whereas MASS's P/E ratio is -16.53. In terms of profitability, SI's ROE is -0.26%, compared to MASS's ROE of -0.25%. Regarding short-term risk, SI is less volatile compared to MASS. This indicates lower risk in terms of short-term price fluctuations for SI.Check MASS's competition here
Mobia Medical, Inc. Common Stock (NASDAQ: MOBI)
SI vs MOBI Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 371.5M. In comparison, MOBI has a market cap of 356.1M. Regarding current trading prices, SI is priced at $17.89 on the NYSE, while MOBI trades at $10.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.36, whereas MOBI's P/E ratio is -0.57. In terms of profitability, SI's ROE is -0.26%, compared to MOBI's ROE of -15.96%. Regarding short-term risk, SI is similarly volatile compared to MOBI. This indicates similar risk in terms of short-term price fluctuations for SI.Check MOBI's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
SI vs ANIK Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 371.5M. In comparison, ANIK has a market cap of 278.9M. Regarding current trading prices, SI is priced at $17.89 on the NYSE, while ANIK trades at $20.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.36, whereas ANIK's P/E ratio is 42.53. In terms of profitability, SI's ROE is -0.26%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, SI is more volatile compared to ANIK. This indicates higher risk in terms of short-term price fluctuations for SI.Check ANIK's competition here
Standard BioTools Inc. (NASDAQ: LAB)
SI vs LAB Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 371.5M. In comparison, LAB has a market cap of 277.6M. Regarding current trading prices, SI is priced at $17.89 on the NYSE, while LAB trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.36, whereas LAB's P/E ratio is -10.13. In terms of profitability, SI's ROE is -0.26%, compared to LAB's ROE of -0.18%. Regarding short-term risk, SI is less volatile compared to LAB. This indicates lower risk in terms of short-term price fluctuations for SI.Check LAB's competition here
Edap Tms S.a. (NASDAQ: EDAP)
SI vs EDAP Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 371.5M. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, SI is priced at $17.89 on the NYSE, while EDAP trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.36, whereas EDAP's P/E ratio is -5.80. In terms of profitability, SI's ROE is -0.26%, compared to EDAP's ROE of -3.13%. Regarding short-term risk, SI is less volatile compared to EDAP. This indicates lower risk in terms of short-term price fluctuations for SI.Check EDAP's competition here
Nyxoah S.A. (NASDAQ: NYXH)
SI vs NYXH Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 371.5M. In comparison, NYXH has a market cap of 155.1M. Regarding current trading prices, SI is priced at $17.89 on the NYSE, while NYXH trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.36, whereas NYXH's P/E ratio is -0.62. In terms of profitability, SI's ROE is -0.26%, compared to NYXH's ROE of -1.80%. Regarding short-term risk, SI is similarly volatile compared to NYXH. This indicates similar risk in terms of short-term price fluctuations for SI.Check NYXH's competition here
Trinity Biotech plc (NASDAQ: TRIB)
SI vs TRIB Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 371.5M. In comparison, TRIB has a market cap of 142.4M. Regarding current trading prices, SI is priced at $17.89 on the NYSE, while TRIB trades at $7.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.36, whereas TRIB's P/E ratio is -0.12. In terms of profitability, SI's ROE is -0.26%, compared to TRIB's ROE of +0.68%. Regarding short-term risk, SI is less volatile compared to TRIB. This indicates lower risk in terms of short-term price fluctuations for SI.Check TRIB's competition here
Apyx Medical Corporation (NASDAQ: APYX)
SI vs APYX Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 371.5M. In comparison, APYX has a market cap of 126.8M. Regarding current trading prices, SI is priced at $17.89 on the NYSE, while APYX trades at $3.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.36, whereas APYX's P/E ratio is -15.05. In terms of profitability, SI's ROE is -0.26%, compared to APYX's ROE of -0.79%. Regarding short-term risk, SI is less volatile compared to APYX. This indicates lower risk in terms of short-term price fluctuations for SI.Check APYX's competition here
SkinHealth Systems Inc. (NASDAQ: SKIN)
SI vs SKIN Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 371.5M. In comparison, SKIN has a market cap of 87.5M. Regarding current trading prices, SI is priced at $17.89 on the NYSE, while SKIN trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.36, whereas SKIN's P/E ratio is -3.07. In terms of profitability, SI's ROE is -0.26%, compared to SKIN's ROE of -0.48%. Regarding short-term risk, SI is less volatile compared to SKIN. This indicates lower risk in terms of short-term price fluctuations for SI.Check SKIN's competition here
DarioHealth Corp. (NASDAQ: DRIO)
SI vs DRIO Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 371.5M. In comparison, DRIO has a market cap of 49.6M. Regarding current trading prices, SI is priced at $17.89 on the NYSE, while DRIO trades at $6.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.36, whereas DRIO's P/E ratio is -1.16. In terms of profitability, SI's ROE is -0.26%, compared to DRIO's ROE of +1.04%. Regarding short-term risk, SI is less volatile compared to DRIO. This indicates lower risk in terms of short-term price fluctuations for SI.Check DRIO's competition here
Spectral AI, Inc. (NASDAQ: MDAI)
SI vs MDAI Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 371.5M. In comparison, MDAI has a market cap of 49.3M. Regarding current trading prices, SI is priced at $17.89 on the NYSE, while MDAI trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.36, whereas MDAI's P/E ratio is -3.44. In terms of profitability, SI's ROE is -0.26%, compared to MDAI's ROE of +1.21%. Regarding short-term risk, SI is more volatile compared to MDAI. This indicates higher risk in terms of short-term price fluctuations for SI.Check MDAI's competition here
HeartBeam, Inc. (NASDAQ: BEAT)
SI vs BEAT Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 371.5M. In comparison, BEAT has a market cap of 22.7M. Regarding current trading prices, SI is priced at $17.89 on the NYSE, while BEAT trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.36, whereas BEAT's P/E ratio is -0.80. In terms of profitability, SI's ROE is -0.26%, compared to BEAT's ROE of -6.87%. Regarding short-term risk, SI is less volatile compared to BEAT. This indicates lower risk in terms of short-term price fluctuations for SI.Check BEAT's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
SI vs BEATW Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 371.5M. In comparison, BEATW has a market cap of 6.3M. Regarding current trading prices, SI is priced at $17.89 on the NYSE, while BEATW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.36, whereas BEATW's P/E ratio is -0.02. In terms of profitability, SI's ROE is -0.26%, compared to BEATW's ROE of -6.87%. Regarding short-term risk, SI is more volatile compared to BEATW. This indicates higher risk in terms of short-term price fluctuations for SI.Check BEATW's competition here
WORK Medical Technology Group Ltd. Class A (NASDAQ: WOK)
SI vs WOK Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 371.5M. In comparison, WOK has a market cap of 4.4M. Regarding current trading prices, SI is priced at $17.89 on the NYSE, while WOK trades at $1.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.36, whereas WOK's P/E ratio is N/A. In terms of profitability, SI's ROE is -0.26%, compared to WOK's ROE of -0.19%. Regarding short-term risk, SI is less volatile compared to WOK. This indicates lower risk in terms of short-term price fluctuations for SI.Check WOK's competition here
QTREX Quantum Ltd. Warrant (NASDAQ: QTEXW)
SI vs QTEXW Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 371.5M. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, SI is priced at $17.89 on the NYSE, while QTEXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.36, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, SI's ROE is -0.26%, compared to QTEXW's ROE of N/A. Regarding short-term risk, SI is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for SI.Check QTEXW's competition here
iTonic Holdings Ltd. (NASDAQ: ITOC)
SI vs ITOC Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 371.5M. In comparison, ITOC has a market cap of 2.8M. Regarding current trading prices, SI is priced at $17.89 on the NYSE, while ITOC trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.36, whereas ITOC's P/E ratio is -0.96. In terms of profitability, SI's ROE is -0.26%, compared to ITOC's ROE of -0.94%. Regarding short-term risk, SI is less volatile compared to ITOC. This indicates lower risk in terms of short-term price fluctuations for SI.Check ITOC's competition here
ENvue Medical, Inc. (NASDAQ: FEED)
SI vs FEED Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 371.5M. In comparison, FEED has a market cap of 798K. Regarding current trading prices, SI is priced at $17.89 on the NYSE, while FEED trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.36, whereas FEED's P/E ratio is -0.01. In terms of profitability, SI's ROE is -0.26%, compared to FEED's ROE of -0.60%. Regarding short-term risk, SI is less volatile compared to FEED. This indicates lower risk in terms of short-term price fluctuations for SI.Check FEED's competition here
Tivic Health Systems, Inc. (NASDAQ: TIVC)
SI vs TIVC Comparison September 2026
Shoulder Innovations, Inc. (NYSE: SI) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SI stands at 371.5M. In comparison, TIVC has a market cap of 279.2K. Regarding current trading prices, SI is priced at $17.89 on the NYSE, while TIVC trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SI currently has a P/E ratio of -10.36, whereas TIVC's P/E ratio is -0.04. In terms of profitability, SI's ROE is -0.26%, compared to TIVC's ROE of -1.65%. Regarding short-term risk, SI is less volatile compared to TIVC. This indicates lower risk in terms of short-term price fluctuations for SI.Check TIVC's competition here